Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study - Tremblay, Gabriel; Daniele, Patrick; Breeze, Janis; Li, Lingling; Shah, Jatin; Shacham, Sharon; Kauffman, Michael; Engelhardt, Monika; Chari, Ajaj; Nooka, Ajay; Vogl, Dan; Gavriatopoulou, Maria; et al. (BMC cancer, 2021)
Gesehen am 11.11.2021